<PAGE> 1
EXHIBIT 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in this Registration Statement on Form S-4 of ICN
Pharmaceuticals, Inc. of our report dated March 2, 2000, which includes an
emphasis-of-a-matter paragraph related to the Company's change in method of
accounting for its investment in ICN Yugoslavia, a previously consolidated
subsidiary, relating to the financial statements and financial statement
schedule of ICN Pharmaceuticals, Inc., which appears in such Registration
Statement. We also consent to the reference to us under the heading "Independent
Accountants" in such Registration Statement.
/s/ PRICEWATERHOUSECOOPERS LLP
-----------------------------------------------------
PricewaterhouseCoopers LLP
Newport Beach, California
June 27, 2000
